Tuberculosis

Bloom, Barry R.; Atun, Rifat; Cohen, Ted; Dye, Christopher; Fraser, Hamish; Gomez, Gabriela B.; Knight, Gwen; Murray, Megan; Nardell, Edward A.; Rubin, Eric; Salomon, Joshua A.; Vassall, Anna; Volchenkov, Grigory; White, Richard Grant; Wilson, Douglas P.; Yadav, Prashant

doi:10.1596/978-1-4648-0524-0_ch11

Cited by 93 publications

(76 citation statements)

References 408 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Without the same resources, external pressure, or validation from donors, autocratic leaders might have less incentive to provide the chronic care and policy-based prevention that tuberculosis, injuries, and many non-communicable diseases require. Our results show that governments, irrespective of GDP, spent more on health as democratic experience increased, which is consistent with the findings of previous studies 44, 45…”

Section: Discussionsupporting

confidence: 93%

The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis

et al. 2019

View full text Add to dashboard Cite

Summary Background Previous analyses of democracy and population health have focused on broad measures, such as life expectancy at birth and child and infant mortality, and have shown some contradictory results. We used a panel of data spanning 170 countries to assess the association between democracy and cause-specific mortality and explore the pathways connecting democratic rule to health gains. Methods We extracted cause-specific mortality and HIV-free life expectancy estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 and information on regime type from the Varieties of Democracy project. These data cover 170 countries and 46 years. From the Financing Global Health database, we extracted gross domestic product (GDP) per capita, also covering 46 years, and Development Assistance for Health estimates starting from 1990 and domestic health spending estimates starting from 1995. We used a diverse set of empirical methods—synthetic control, within-country variance decomposition, structural equation models, and fixed-effects regression—which together provide a robust analysis of the association between democratisation and population health. Findings HIV-free life expectancy at age 15 years improved significantly during the study period (1970–2015) in countries after they transitioned to democracy, on average by 3% after 10 years. Democratic experience explains 22·27% of the variance in mortality within a country from cardiovascular diseases, 16·53% for tuberculosis, and 17·78% for transport injuries, and a smaller percentage for other diseases included in the study. For cardiovascular diseases, transport injuries, cancers, cirrhosis, and other non-communicable diseases, democratic experience explains more of the variation in mortality than GDP. Over the past 20 years, the average country's increase in democratic experience had direct and indirect effects on reducing mortality from cardiovascular disease (−9·64%, 95% CI −6·38 to −12·90), other non-communicable diseases (−9·14%, −4·26 to −14·02), and tuberculosis (−8·93%, −2·08 to −15·77). Increases in a country's democratic experience were not correlated with GDP per capita between 1995 and 2015 (ρ=–0·1036; p=0·1826), but were correlated with declines in mortality from cardiovascular disease (ρ=–0·3873; p<0·0001) and increases in government health spending (ρ=0·4002; p<0·0001). Removal of free and fair elections from the democratic experience variable resulted in loss of association with age-standardised mortality from non-communicable diseases and injuries. Interpretation When enforced by free and fair elections, democracies are more likely than autocracies to lead to health gains for causes of mortality (eg, cardiovascular diseases and transport injuries) that have not been heavily targeted by foreign aid and require health-care delivery infrastructure. International health agencies and donors might increasingly need t...

show abstract

Section: Discussionsupporting

confidence: 93%

The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (Mtb), is associated with high morbidity and mortality, thus posing a global public health problem. In 2017, TB ranked as one of the top ten causes of death, with an estimated 10 million new cases and 1.6 million deaths [ 1 ]. In addition, approximately 1.7 billion people, 23% of the global population, are estimated to have latent TB infection and to be at risk of developing active TB during their lifetime.…”

Section: Introductionmentioning

confidence: 99%

Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine

et al. 2020

View full text Add to dashboard Cite

The antigen-specific Th17 responses in the lungs for improved immunity against Mycobacterium tuberculosis (Mtb) infection are incompletely understood. Tuberculosis (TB) vaccine candidate HSP90-ESAT-6 (E6), given as a Bacillus Calmette-Guérin (BCG)-prime boost regimen, confers superior long-term protection against the hypervirulent Mtb HN878 infection, compared to BCG or BCG-E6. Taking advantage of protective efficacy lead-out, we found that ESAT-6-specific multifunctional CD4+IFN-γ+IL-17+ T-cells optimally correlated with protection level against Mtb infection both pre-and post-challenge. Macrophages treated with the supernatant of re-stimulated lung cells from HSP90-E6-immunised mice significantly restricted Mtb growth, and this phenomenon was abrogated by neutralising anti-IFN-γ and/or anti-IL-17 antibodies. We identified a previously unrecognised role for IFN-γ/IL-17 synergism in linking anti-mycobacterial phagosomal activity to enhance host control against Mtb infection. The implications of our findings highlight the fundamental rationale for why and how Th17 responses are essential in the control of Mtb, and for the development of novel anti-TB subunit vaccines.

show abstract

“…While several factors contribute to natural differences in human immunity to disease, this PERSPECTIVE article focuses mainly on host genetic factors as one of the main drivers for outcomes of infectious diseases, specifically TB (Abel et al, 2014). In the current state, the BCG vaccine for TB elicits highly variable protection in different human populations, and anti-TB drugs might work well in one person but be less effective or cause serious side effects in another (Bloom et al, 2017). Therefore, knowing the underlying relationship between genetics and biology will enable us to identify those individuals who will benefit maximally from designed therapies and vaccines.…”

Section: Importance Of Inter-individual Human Immune Response Variatimentioning

confidence: 99%

Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines

Azad

Lloyd

Sadée

et al. 2020

Front. Cell. Infect. Microbiol.

View full text Add to dashboard Cite

Universal approaches to the prevention and treatment of human diseases fail to take into account profound immune diversity resulting from genetic variations across populations. Personalized or precision medicine takes into account individual lifestyle, environment, and biology (genetics and immune status) and is being adopted in several disease intervention strategies such as cancer and heart disease. However, its application in infectious diseases, particularly global diseases such as tuberculosis (TB), is far more complex and in a state of infancy. Here, we discuss the impact of human genetic variations on immune responses and how they relate to failures seen in current TB diagnostic, therapy, and vaccine approaches across populations. We offer our perspective on the challenges and potential for more refined approaches going forward.

show abstract

Tuberculosis

Cited by 93 publications

References 408 publications

The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis

The relationships between democratic experience, adult health, and cause-specific mortality in 170 countries between 1980 and 2016: an observational analysis

Antigen-Specific IFN-γ/IL-17-Co-Producing CD4+ T-Cells are the Determinants for Protective Efficacy of Tuberculosis Subunit Vaccine

Challenges of Immune Response Diversity in the Human Population Concerning New Tuberculosis Diagnostics, Therapies, and Vaccines

Contact Info

Product

Resources

About